Want to join the conversation?
The Dublin, Ohio-based prescription drug distributor $CAH said that in generics, the company continues to grow its base of customers spanning independent pharmacies, chain, institutional and hospital pharmacies. The company saw a steep growth in its specialty solutions business in 2Q16 and expects its sales to exceed $8Bil in FY16.
$BABA seems to be on a roll! But increasing its yearly sales outlook from 48% to 54% seems over-expectation from the company's part, doesn't it?
$JNJ down 2% in pre-market trading. Earnings beat expectations, but sales disappointed. Johnson is cautious on its outlook. How it will perform in the future?
$YHOO is reporting today after market close. Nobody cares about this stock.